Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01351727|
Recruitment Status : Completed
First Posted : May 11, 2011
Last Update Posted : November 6, 2017
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||97 participants|
|Official Title:||Epidemiologic Follow Up Study of Newly Diagnosed Epilepsy Among Seniors From Different Ethnic Groups|
|Study Start Date :||January 2011|
|Actual Primary Completion Date :||September 2014|
|Actual Study Completion Date :||September 2014|
Seniors with Seizures
Seniors aged 65 or older with newly diagnosed seizures (consistent with epilepsy) or epilepsy as of October, 2010.
- A two-year incidence rate of new-onset seizures and/or newly-diagnosed epilepsy among seniors in southeastern Arizona. [ Time Frame: Up to four years ]A surveillance mechanism will be developed to identify and recruit seniors from emergency departments, neurology clinics, primary care clinics, and other service providers for seniors.
- Compare the impact of epilepsy on the different ethnic groups of seniors with epilepsy [ Time Frame: Up to four years ]
- Assess the level and ethnic differences in health-related quality of life, mental health, and perceived stigma among seniors with seizures.
- Use in-depth interviews to explore issues related to epilepsy and its treatment.
- Conduct focus groups with caregivers to learn about their concerns and barriers.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01351727
|United States, Arizona|
|Pima, Cochise, Santa Cruz Counties|
|Tucson, Arizona, United States, 85724|
|Principal Investigator:||David Labiner, MD||University of Arizona|
|Principal Investigator:||Jenny Chong, PhD||University of Arizona|